Completed NICE / NIHR Projects
HTAs / MTAs/ DARs
Project ID |
Project Title |
Project lead |
| 15/64/11 | Joshua Pink | |
| 13/177 |
Canagliflozin, dapagliflozin and empagliflozin for Diabetes (monotherapy) [ID756] |
Norman Waugh |
| 13/111 |
Fluorouracil plasma monitoring: the My5-FU assay for guiding dose adjustment in patients receiving fluorouracil chemotherapy by continuous infusion |
Paul Sutcliffe |
| 13/178 |
Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control (update) |
Paul Sutcliffe |
| 13/60 |
Empagliflozin for type 2 diabetes |
Norman Waugh |
| 14/69/03 |
The LISA-TRACKER anti-tumour necrosis factor (anti-TNF) assay kits, used for monitoring anti-TNF drugs and antibodies in people with inflammatory bowel disease |
KarolineFreeman |
| 12/71 | Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation | Norman Waugh |
| 11/118 | Total hip replacement and surface replacement for the treatment of pain and disability resulting from end-stage arthritis of the hip (review of technology appraisal guidance 2 and 44): systematic review and economic evaluation | Aileen Clarke |
| 12/02/01 | Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model | Paul Sutcliffe |
| 11/130/02 | Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews | Paul Sutcliffe |
| 2012/48 | Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation | Norman Waugh |
| 13/08 | Clinical effectiveness and cost-effectiveness of elemental nutrition for the maintenance of remission in Crohn s disease: a systematic review and meta-analysis | Paul Sutcliffe |
| 10/91 | A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression | Paul Sutcliffe |
STAs
Project ID |
Project title |
Project lead |
| 15/07/02 |
Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene [ID428] |
Aileen Clarke |
| 14/148/05 |
Idelalisib for chronic lymphocytic, previously treated leukaemia |
Aileen Clarke |
| 14/56 |
LDK378 for previously treated anaplastic-lymphoma-kinase-positive non-small-cell lung cancer [ID729] |
James Mason |
| 15/69/07 |
Ramucirumab for previously treated locally advanced or metastatic non-small-cell lung cancer |
Aileen Clarke |